	Multicenter randomized effectiveness/implementation trial of a digital self-management support tool to improve the quality of life during adjuvant hormonal therapy for patients with early breast cancer: The HOPE trial. Contemp Clin Trials Franzoi MA, Michels S, Ball S, Barbier A, Serhal C, Bernatowiez A, Ferreira A, D'Andon JF, Gernier F, Morel A, Demetz J, Le Du F, Lapidari P, Vaz-Luis I. PMID: 42501860 [PubMed - as supplied by publisher]
	Awareness Is Not Enough: Global Evidence on Breast Cancer Knowledge and Self- Screening Practices Among Young Women. J Cancer Policy Ragendu R, Naman, Gupta R, Arya R, Jindal R, Kanozia R. PMID: 42501835 [PubMed - as supplied by publisher]
	Patient-reported outcomes from the TBCRC 022 study of neratinib and ado-trastuzumab emtansine for HER2-positive breast cancer brain metastases. Breast Grinda T, Heiling HM, Tayob N, Smith KL, Davis R, Cotter C, DeMeo MK, Santa-Maria CA, Van Poznak C, Moy B, Brufsky AM, Melisko ME, O'Sullivan CC, Isaacs C, Rauf Y, Nangia JR, Burns RT, Savoie J, Wolff AC, Winer EP, Mayer EL, Tolaney SM, Rimawi MF, Ruddy KJ, Rocque G, Krop IE, Lin NU, Freedman RA. PMID: 42501479 [PubMed - as supplied by publisher]
	Cadonilimab for recurrent small cell neuroendocrine carcinoma of the cervix: a phase 2 study. Int J Gynecol Cancer Clark HD, Frumovitz M, Rangel KM, Li Z, Yuan Y, Westin SN, Jazaeri AA, Meyer LA, Sims TT. PMID: 42501476 [PubMed - as supplied by publisher]
	Changes in the extensiveness of initial debulking surgery with increasing neoadjuvant chemotherapy use in advanced ovarian cancer: a nationwide population-based study. J Gynecol Oncol Kim J, Oh BC, Kang S. PMID: 42501262 [PubMed - as supplied by publisher]
	Cellular effects of combined Ctn-2 peptide and doxorubicin treatment in breast cancer cells: A preliminary study of membrane interaction, ROS production, and cell cycle distribution. Mol Biol Rep Sepúlveda AM, Manrique-Moreno M, Echeverri-Gaviria S, Santa-González GA. PMID: 42501149 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Olaparib Combined With Cediranib in the Treatment of Ovarian Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Technol Cancer Res Treat Li S, Zhang J, Chen A. PMID: 42500959 [PubMed - indexed for MEDLINE]
	Artificial Intelligence for Breast Cancer Molecular Subtype Prediction From Medical Imaging: A Systematic Review of Literature. Technol Cancer Res Treat Morales-Duran JC, Osorno-Castillo K, Díaz GM. PMID: 42500935 [PubMed - indexed for MEDLINE]
	Pulmonary Tumor Thrombotic Microangiopathy Diagnosed by Right Heart Catheterization in a Patient With Breast Cancer: A Case Report. Cureus Tajima S, Nakata Y, Sanda K, Koshimo Y, Shigematsu M. PMID: 42500795 [PubMed]
	Clinicopathological Spectrum of Ovarian Tumors and Diagnostic Utility of Cancer Antigen 125 (CA-125): An Observational Study From Eastern India. Cureus Choudhary A, Paswan MK, Jamaiyar A. PMID: 42500789 [PubMed]
	Frequency and clinicopathological features of somatic neoplasms arising in ovarian mature teratomas: a single-center experience. Pathol Oncol Res Y, Bülbül GA, Nergiz D, Y, Önder AH, Üreyen I. PMID: 42500623 [PubMed - indexed for MEDLINE]
	PRR11 expression in early ER+/HER2-low breast cancer: Association with estrogen receptor positivity and exploratory analysis of prognostic significance. Oncol Lett Turkel A, Dogan M, Irkkan SC, Erdem HB, Bozdogan N, Bahsi T. PMID: 42500608 [PubMed]
	Research Advances in Drug Resistance Mechanisms to Anti-HER2 Therapy in HER2-Positive Breast Cancer. Oncol Res Huang C, Kong J, Ren H, Zhang W, Jiang S, Sheng X. PMID: 42500590 [PubMed - indexed for MEDLINE]
	Navigating the Metabolic-Genomic Paradigm: Mitochondrial Reprogramming as a Driver of Cancer Plasticity. Oncol Res Tzeng YT, Wen CY, Yong SB, Wen ZH, Chiang AJ, Li CJ. PMID: 42500587 [PubMed - indexed for MEDLINE]
	The Intratumoral Microbiota in Breast Cancer: Roles in Progression, Immunity, and Therapy. Oncol Res Wei Z, Cai J, Wang S, Li Y, Luo L, Chen J, Li F, Nie H, Gong K, Cai M. PMID: 42500581 [PubMed - indexed for MEDLINE]
	Breast Cancer Cell-Derived Exosomal miR-92b-3p Promotes Tumor Angiogenesis and Metastasis by Suppressing PTEN in Vascular Endothelial Cells. Oncol Res Yang T, Guan M, Guan X, Kang L, Wang X, Guan Y, Yang Y, Deng W, Wang G. PMID: 42500570 [PubMed - indexed for MEDLINE]
	Association of MT1A rs11640851, rs8052394 and rs11076161 Polymorphisms with the Risk of Developing Breast Cancer: A Haplotype-Based Case-Control Study and in Silico Analysis. Indian J Clin Biochem Shirvani M, Yadollahi A, Zamanzadeh Z, Abkar M, Yousefnia S. PMID: 42500341 [PubMed]
	Higher Incidence of Anemia and Clinical Utility of Indices of Iron Homeostasis in Newly Diagnosed Breast Cancer Patients: A Cross-Sectional Study from a Regional Oncology Centre of South India. Indian J Clin Biochem Parameswari R, Bobby Z, Kayal S, Prabhu M, Nisha Y, Thalapalliyil K. PMID: 42500333 [PubMed]
	Machine learning-based prognostic model for triple-negative breast cancer with axillary lymph node metastasis. Front Oncol Huang R, Jiang T, Lv X, Yao N, Guo Y. PMID: 42500284 [PubMed]
	Gut microbiota and polyendocrine metabolic ovarian syndrome: an integrated gut-metabolism-endocrine-ovary axis. Exp Biol Med (Maywood) Jin S, Zhu M, Lu Y, Zhao J, Zhu J, Fang X. PMID: 42500257 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 332723

Page 1 of 16637



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy